Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 Function
Sungim Choi, Heun Choi, Seong Yeon Park, Yee Gyung Kwak, Je Eun Song, So Youn Shin, Ji Hyeon Baek, Hyun-IL Shin, Hong Sang Oh, Yong Chan Kim, Joon-Sup Yeom, Jin-Hee Han, Min Jae Kim
Korean J Parasitol. 2022;60(1):39-43.   Published online 2022 Feb 23     DOI: https://doi.org/10.3347/kjp.2022.60.1.39
Citations to this article as recorded by Crossref logo
Capecitabine/oxaliplatin/primaquine
Reactions Weekly.2022; 1902(1): 124.     CrossRef
Cost-Benefit Analysis of Tafenoquine for Radical Cure of Plasmodium vivax Malaria in Korea
Jiyeon Suh, Jung Ho Kim, Jong-Dae Kim, Changsoo Kim, Jun Yong Choi, Jeehyun Lee, Joon-Sup Yeom
Journal of Korean Medical Science.2022;[Epub]     CrossRef
Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure
Kamonwan Chamchoy, Sirapapha Sudsumrit, Thanyapit Thita, Srivicha Krudsood, Rapatbhorn Patrapuvich, Usa Boonyuen, Paul O. Mireji
PLOS Neglected Tropical Diseases.2022; 16(12): e0010986.     CrossRef